Boosting Biopharma SMEs in Europe

By João L. Carapinha

November 26, 2024

In a recent update, the European Federation of Pharmaceutical Industries and Associations (EFPIA) emphasizes the critical challenges faced by biopharmaceutical Small and Medium-Sized Enterprises (SMEs) in Europe. The update focusses on the urgent ...
Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
Rising Diabetes Prevalence in the Middle East and North Africa
GCC Healthcare Concerns: Key Challenges and Solutions for Residents
Diabetes in the MENA Region: Challenges and Solutions
Diabetes Crisis in Europe: Urgent Public Health and Economic Challenge
G20 Health Working Group Prioritizes Resilience, Equity, and Climate Change
Healthcare for Older Adults in Türkiye: A Call for Reform
Oman Healthcare Development: A Vision for Self-Reliance and Innovation
Leveraging Bayh-Dole Act March-In Rights to Reduce US Drug Prices
Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution
Saudi Healthcare Reform: Vision 2030 and Beyond